A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment

References

• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239–12 41.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095.
   PubMed Web of Science ®Google Scholar
• Graff K, Smith C, Silveira L, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Dis J. 2021;40(4):e137–e145.
   PubMed Web of Science ®Google Scholar
• Götzinger F, Santiago-García B, Noguera-Julián A, ptbnet COVID-19 Study Group, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653–661.
   PubMedGoogle Scholar
• Aydillo T, Gonzalez-Reiche AS, Aslam S, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020;383(26):2586–2588.
   PubMed Web of Science ®Google Scholar
• Gottlieb RL, Vaca CE, Paredes R, GS-US-540-9012 (PINETREE) Investigators, et al. Early remdesivir to prevent progression to severe covid-19 in outpatients. N Engl J Med. 2022;386(4):305–315.
   PubMed Web of Science ®Google Scholar
• National Institute of Health (NIH). NIH COVID-19 Treatment Guidelines: Clinical Spectrum of SARS-CoV-2 Infection. 2022. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum
   Google Scholar
• Madhusoodhan PP, Pierro J, Musante J, et al. Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience. Pediatr Blood Cancer. 2021;68(3):e28843.
   PubMed Web of Science ®Google Scholar
• Bullard J, Dust K, Funk D, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. 2020;71(10):2663–2666.
   PubMed Web of Science ®Google Scholar
• Mukkada S, Bhakta N, Chantada GL, Global Registry of COVID-19 in Childhood Cancer, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22(10):1416–1426.
   PubMed Web of Science ®Google Scholar
• Müller J, et al. Clinical Course of COVID-19 disease in children treated with neoplastic diseases in Hungary. Pathol Oncol Res. 2022;28:1610261.
   PubMed Web of Science ®Google Scholar
• Mercolini F, Cesaro S. COVID-19 in children and adolescents: characteristics and specificities in immunocompetent and oncohematological patients. Mediterr J Hematol Infect Dis. 2022;14(1):e2022009.
   PubMed Web of Science ®Google Scholar
• Węcławek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, et al. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a polish national study. J Hematol Oncol. 2021;14(1):163.
   PubMed Web of Science ®Google Scholar
• Hammad M, Shalaby L, Sidhom I, et al. Management and outcome of coronavirus disease 2019 (COVID-19) in pediatric cancer patients: a single Centre experience from a developing country. Clin Lymphoma Myeloma Leuk. 2021;21(11):e853–e864.
   PubMed Web of Science ®Google Scholar
• Stokes CL, Patel PA, Sabnis HS, et al. Severe COVID-19 disease in two pediatric oncology patients. Pediatr Blood Cancer. 2020;67(9):e28432.
   PubMed Web of Science ®Google Scholar
• Vicent MG, Martinez AP, Trabazo Del Castillo M, et al. COVID-19 in paediatric hematopoietic stem cell transplantation: the experience of spanish group of transplant (GETMON/GETH). Pediatr Blood Cancer. 2020;67(9):e28514.
   PubMed Web of Science ®Google Scholar
• Andre N, Rouger-Gaudichon J, Brethon B, et al. COVID-19 in pediatric oncology from french pediatric oncology and hematology centers: high risk of severe forms? Pediatr Blood Cancer. 2020;67(7):e28392.
   PubMed Web of Science ®Google Scholar
• Smith VR, Whittle SB, Coleman RD, et al. Severe COVID-19 infection in a child receiving immunotherapy for cancer. Pediatr Blood Cancer. 2021;68(3):e28710.
   PubMed Web of Science ®Google Scholar
• Biscarini S, Villa S, Tomasello M, et al. Safety profile and outcomes of early COVID-19 treatments in immunocompromised patients: a single Centre cohort study. Biomedicines. 2022;10(8):2002.
   PubMed Web of Science ®Google Scholar
• Lafont E, Pere H, Lebeaux D, et al. Targeted SARS-CoV2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19. J Antimicrob Chemother. 2022;77(10):2688–2692.
   PubMed Web of Science ®Google Scholar
• Jaroszewicz J, Kowalska J, Pawłowska M, et al. Remdesivir decreases mortality in COVID-19 patients with active malignancy. Cancers. 2022;14(19):4720.
   PubMed Web of Science ®Google Scholar
• Aksak-Wąs BJ, Chober D, Serwin K, et al. Remdesivir reduces mortality in hemato-oncology patients with COVID-19. J Inflamm Res. 2022;15:4907–4920.
   PubMed Web of Science ®Google Scholar
• Dolan SA, Mulcahy Levy J, Moss A, et al. SARS-CoV-2 persistence in immunocompromised children. Pediatr Blood Cancer. 2021;68(12):e29277.
   PubMed Web of Science ®Google Scholar
• Haidar G, Mellors JW. Improving the outcomes of immunocompromised patients with coronavirus disease 2019. Clin Infect Dis. 2021;73(6):e1397-1401–e1401.
   Web of Science ®Google Scholar
• Sepulcri C, Dentone C, Mikulska M, et al. The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient – a case study. Open Forum Infect Dis. 2021;8(11):ofab217.
   PubMed Web of Science ®Google Scholar
• Han MS, Choi EH, Chang SH, et al. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic Of Korea. JAMA Pediatr. 2021;175(1):73–80.
   PubMed Web of Science ®Google Scholar
• Kam KQ, Thoon KC, Maiwald M, et al. SARS-CoV2 viral RNA load dynamics in the nasopharynx of infected children. Epidemiol Infect. 2021;149:e18.
   PubMed Web of Science ®Google Scholar
• Xu CLH, Raval M, Schnall JA, et al. Duration of respiratory and gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and synthesis of data. Pediatr Infect Dis J. 2020;39(9):e249-56–e256.
   Web of Science ®Google Scholar
• Corey L, Beyrer C, Cohen MS, et al. SARS-CoV2 variants in immunosuppressed individuals. N Engl J Med. 2021;385(6):562–566.
   PubMed Web of Science ®Google Scholar
• Goldman DL, Aldrich ML, Hagmann SHF, et al. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5):e2020047803.
   PubMed Web of Science ®Google Scholar
• Méndez-Echevarría A, Pérez-Martínez A, Gonzalez del Valle L, et al. Compassionate use of remdesivir in children with COVID-19. Eur J Pediatr. 2021;180(4):1317–1322.
   PubMed Web of Science ®Google Scholar
• U.S. National Library of Medicine. Study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of remdesivir (GS-5734TM) in participants from birth to <18 years of age with Coronavirus Disease 2019 (COVID-19) (CARAVAN). ClinicalTrials.gov identifier: NCT04431453. 2020. http://clinicaltrials.gov/ct2/show/NCT04431453
   Google Scholar
• Ahmed A, Rojo P, Agwu A, et al. Remdesivir treatment for COVID-19 in hospitalized children: CARAVAN interim results. In Conference on Retroviruses and Opportunistic Infections (CROI) 2022 Annual Meeting; 2022. Denver, CO. Abstract 744.
   Google Scholar
• Eleftheriou I, Liaska M, Krepis P, et al. Sinus bradycardia in children with remdesivir for COVID-19. Pediatr Infect Dis J. 2021;40(9):e356.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Maust B, Kazmier KM, et al. Sinus Bradycardia in a pediatric patient treated with remdesivir for acute coronavirus disease 2019: a case report and a review of the literature. J Ped Infect Dis Soc. 2021;10(9):926–929.
   PubMed Web of Science ®Google Scholar
• Sanchez-Codez MI, Rodriguez-Gonzalez M, Gutierrez-Rosa I. Severe sinus bradycardia associated with remdesivir in children with severe SARS-CoV-2 infection. Eur J Pediatr. 2021;180(5):1627.
   PubMed Web of Science ®Google Scholar
• Zapor M. Persistent detection and infectious potential of SARS-CoV-2 virus in clinical specimens from COVID-19 patients. Viruses. 2020;12(12):1384.
   PubMed Web of Science ®Google Scholar